Govt job: For Ph.D, M.Pharm, M.Sc under Ministry of S & T | Salary upto Rs. 1,50,000 pm

Institute of Life Sciences (ILS), Bhubaneswar is a leading national institute in India. It is a multidisciplinary institute engaged in advanced research in Infectious Disease Biology, Cancer Biology, Genetics & Autoimmune Diseases, and Plant & Microbial Biotechnology.

Post : Project Associate-I/NGS Data Analyst, Lab Technician, Quality control consultant / Research Associate

Position : 1 Project Associate-I / NGS Data Analyst (1)

Project Title :  Documentation and Validation of Traditional Healthcare Knowledge of Indian Himalayan Region: Translational approach

Remuneration : Rs.31,000/- + @ 16% HRA per month

Eligibility Criteria : Candidates having M.Sc. / M. Tech / M. Pharm. / M.V.Sc. or equivalent qualification in Life Sciences or allied subjects (Biochemistry/ Biotechnology/ Bioinformatics/ computational Biology, Microbiology etc.) with a minimum of 60% aggregate marks (relaxation will be given as per GOI guideline) are eligible to apply. Candidate having experience in Next Generation Sequencing (NGS) data analysis and working knowledge of Linux, Python and R will be given preference.

Preference will be given to national level entrance test (NET/GATE/GPAT) qualified candidates. For non-NET/GATE candidates, the fellowship would be applicable as per DST guidelines.

Age Limit : The upper age limit of the candidate should be below 35 years as on last date of application. Age relaxation will be given to the candidates as per Govt. of India rules.

Position : 2 Lab Technician (1)

Project Title : Documentation and Validation of Traditional Healthcare Knowledge of Indian Himalayan Region: Translational approach.

Remuneration : Rs.20,000/- + @ 16% HRA per monthEligibility Criteria : B.Sc. in any branch of Life Science. Candidates having working experience in Biological research laboratories and DMLT qualification will be preferred.

Position : 3 Quality control consultant / Research Associate (2)

Project Title : Establish state of the art clinical-immunogenicity assay platform to facilitate COVID-19 vaccine development.

Remuneration : Rs. 1,50,000/- per month (consolidated) (negotiable based on experience).

Eligibility Criteria : M.Sc. / Ph.D. in any branch of Biological Science/ Life Science with minimum 5 years of research experience.

Desirable : Experience in assessing and guiding on the quality assessment parameters of assays, report generation, SOP generation, documentation and application for ISO and NABL accreditation. Candidates with Ph.D. in Immunology or extensive expertise in Immunological techniques like Flow Cytometry, ELISA and cell culture will be preferred.

Age Limit : The upper age limit of the candidate should be below 50 years as on last date of application. Age relaxation will be given to the candidates as per Govt. of India rules.

Selection will be carried out through application screening, followed by an interview process.

Interested/eligible candidates may download application form from the institute website (ils.res.in ) and apply along with self-attested copies of mark sheets, certificates and other relevant documents to the “Director, Institute of Life Sciences, Nalco Square, Bhubaneswar-751023.” Super-scribe the envelope with “Position No…… and Application for the position of ………..” N.B.:

The list of shortlisted candidates name and the date of interview will be published on the ILS website. All the positions are purely temporary and coterminous with the project. No TA/DA will be paid for attending the interview.

The decision of the Director regarding selection of candidates will be final and no further correspondence will be entertained in this regard.

Note : All communication will be through e-mail. No separate call letter will be issued to the candidates.

Last date of receipt of application :17.05.2022

Date of publishing the name of shortlisted candidates on the website : 20.05.2022

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March